SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-086152
Filing Date
2017-03-17
Accepted
2017-03-17 06:10:35
Documents
9
Period of Report
2017-04-27
Effectiveness Date
2017-03-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d325218ddef14a.htm DEF 14A 663660
2 GRAPHIC g301303g11y77.jpg GRAPHIC 26592
3 GRAPHIC g301303g21j11.jpg GRAPHIC 24658
4 GRAPHIC g301303g49a18.jpg GRAPHIC 25012
5 GRAPHIC g301303g56z83.jpg GRAPHIC 16586
6 GRAPHIC g301303g57f70.jpg GRAPHIC 22487
7 GRAPHIC g325218g27s88.jpg GRAPHIC 26209
8 GRAPHIC g325218g55a13.jpg GRAPHIC 44527
9 GRAPHIC g325218g58j69.jpg GRAPHIC 31399
  Complete submission text file 0001193125-17-086152.txt   965086
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36569 | Film No.: 17696288
SIC: 2835 In Vitro & In Vivo Diagnostic Substances